Elkedonia

Elkedonia is an antidepressant therapy development company dedicated to transforming the treatment of mental health disorders. Elkedonia is introducing a first-class antidepressant approach utilizing precision medicine. The lead drug discovery program targets the inhibition of the intracellular Elk1 protein to address the needs of treatment-resistant depression (TRD).